APA

Carmona S., Jorgensen M. R., Kolli S., Crowther C., Salazar F. H., Marion P. L., Fujino M., Natori Y., Thanou M., Arbuthnot P. & Miller A. D. (20090806). Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles. : Molecular pharmaceutics.

Chicago

Carmona Sergio, Jorgensen Michael R, Kolli Soumia, Crowther Carol, Salazar Felix H, Marion Patricia L, Fujino Masato, Natori Yukikazu, Thanou Maya, Arbuthnot Patrick and Miller Andrew D. 20090806. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles. : Molecular pharmaceutics.

Harvard

Carmona S., Jorgensen M. R., Kolli S., Crowther C., Salazar F. H., Marion P. L., Fujino M., Natori Y., Thanou M., Arbuthnot P. and Miller A. D. (20090806). Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles. : Molecular pharmaceutics.

MLA

Carmona Sergio, Jorgensen Michael R, Kolli Soumia, Crowther Carol, Salazar Felix H, Marion Patricia L, Fujino Masato, Natori Yukikazu, Thanou Maya, Arbuthnot Patrick and Miller Andrew D. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles. : Molecular pharmaceutics. 20090806.